Balance Sheet Nomura Research Institute, Ltd.

Equities

4307

JP3762800005

IT Services & Consulting

Delayed Japan Exchange Other stock markets 08:00:00 19/02/2026 am IST			5-day change	1st Jan Change
3,951.00 ^JPY	+1.57%		-6.37%	-34.38%

08/02	Japan's Takaichi set for major lower house victory	RE
08/02	INSTANT VIEW-Japan's Takaichi set for major lower house victory	RE

ae6bbf100.qMJ7hn_KDFZtis81AvydeBDCwOWlc8EfuzxLn-xshwY.26YZ1yiHfGdfuI0EYMWrPni2soPsJod041Nmrd8LvjSY7zDDKaJ4Y1_oig

Published financial data: NOMURA RESEARCH INSTITUTE, LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	55TCr	61TCr	69TCr	74TCr	76TCr
Total Revenues	55TCr	61TCr	69TCr	74TCr	76TCr
Cost of Goods Sold, Total	36TCr	40TCr	45TCr	48TCr	49TCr
Gross Profit	19TCr	22TCr	24TCr	26TCr	28TCr
Selling General & Admin Expenses, Total	9.84TCr	11TCr	13TCr	14TCr	14TCr
Provision for Bad Debts	-	-	-	-	-
Depreciation & Amortization - (IS)	-	-	-	-	-
Amortization of Goodwill and Intangible Assets - (IS)	-	-	-	-	-
Other Operating Expenses	452.6Cr	-12Cr	-133.1Cr	-28Cr	-260.4Cr
Other Operating Expenses, Total	10TCr	11TCr	13TCr	14TCr	14TCr
Operating Income	8.29TCr	10TCr	11TCr	12TCr	13TCr
Interest Expense, Total	-100.5Cr	-138.2Cr	-480.7Cr	-609.5Cr	-568.4Cr
Interest And Investment Income	125.8Cr	170.5Cr	206.6Cr	340.5Cr	425.5Cr
Net Interest Expenses	25Cr	32Cr	-274.1Cr	-269Cr	-142.9Cr
Income (Loss) On Equity Invest.	6.2Cr	20Cr	45Cr	78Cr	90Cr
Currency Exchange Gains (Loss)	-	-	-	-	-
Other Non Operating Income (Expenses)	-992.5Cr	-187.2Cr	-59Cr	-50Cr	68Cr
EBT, Excl. Unusual Items	7.33TCr	10TCr	11TCr	12TCr	13TCr
Gain (Loss) On Sale Of Investments	-	-	-44Cr	143Cr	1.5Cr
Gain (Loss) On Sale Of Assets	-	335.6Cr	223.9Cr	1.5Cr	-
Asset Writedown	-222Cr	-	-	-75Cr	16Cr
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	7.11TCr	10TCr	11TCr	12TCr	13TCr
Income Tax Expense	1.85TCr	3.29TCr	3.2TCr	3.71TCr	3.98TCr
Earnings From Continuing Operations	5.26TCr	7.18TCr	7.65TCr	8.02TCr	9.44TCr
Net Income to Company	5.26TCr	7.18TCr	7.65TCr	8.02TCr	9.44TCr
Minority Interest	29Cr	-35Cr	-19Cr	-52Cr	-62Cr
Net Income - (IS)	5.29TCr	7.14TCr	7.63TCr	7.96TCr	9.38TCr
Net Income to Common Incl Extra Items	5.29TCr	7.14TCr	7.63TCr	7.96TCr	9.38TCr
Net Income to Common Excl. Extra Items	5.29TCr	7.14TCr	7.63TCr	7.96TCr	9.38TCr
Per Share Items
Net EPS - Basic	88.34	120.57	128.92	136.9	163.56
Basic EPS - Continuing Operations	88.34	120.57	128.92	136.9	163.56
Basic Weighted Average Shares Outstanding	60Cr	59Cr	59Cr	58Cr	57Cr
Net EPS - Diluted	88.12	120.34	128.88	136.84	163.56
Diluted EPS - Continuing Operations	88.12	120.34	128.88	136.84	163.56
Diluted Weighted Average Shares Outstanding	60Cr	59Cr	59Cr	58Cr	57Cr
Normalized Basic EPS	77.03	106.27	112.34	124.3	145
Normalized Diluted EPS	76.84	106.07	112.31	124.24	144.99
Dividend Per Share	36	40	45	53	63
Payout Ratio	38.41	31.7	33.25	34.63	35.53
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	12TCr	14TCr	15TCr	17TCr	18TCr
EBITA	8.29TCr	10TCr	11TCr	12TCr	13TCr
EBIT	8.29TCr	10TCr	11TCr	12TCr	13TCr
EBITDAR	-	-	-	-	-
Effective Tax Rate - (Ratio)	26.02	31.41	29.5	31.62	29.65
Normalized Net Income	4.61TCr	6.3TCr	6.65TCr	7.23TCr	8.31TCr
Non-Cash Pension Expense	400.7Cr	608.9Cr	694.9Cr	756.3Cr	770.2Cr
Supplemental Operating Expense Items
General and Administrative Expenses	-	-	-	-	-
Research And Development Expense From Footnotes	446.8Cr	499.2Cr	490.8Cr	530.1Cr	611.4Cr
Net Rental Expense, Total	-	-	-	-	-
Imputed Operating Lease Interest Expense	-	-	-	-	-
Imputed Operating Lease Depreciation	-	-	-	-	-

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	15TCr	12TCr	13TCr	17TCr	17TCr
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	15TCr	12TCr	13TCr	17TCr	17TCr
Accounts Receivable, Total	11TCr	14TCr	13TCr	14TCr	16TCr
Total Receivables	11TCr	14TCr	13TCr	14TCr	16TCr
Inventory	-	-	-	-	-
Prepaid Expenses	-	-	-	-	-
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	6.39TCr	8.24TCr	8.83TCr	8.94TCr	9.25TCr
Total Current Assets	32TCr	33TCr	35TCr	41TCr	42TCr
Net Property Plant And Equipment	9.03TCr	7.65TCr	7.4TCr	6.91TCr	6.07TCr
Long-term Investments	15TCr	16TCr	17TCr	18TCr	17TCr
Goodwill	2.04TCr	9.55TCr	10TCr	11TCr	11TCr
Other Intangibles, Total	6.87TCr	12TCr	14TCr	15TCr	16TCr
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	534.1Cr	542.6Cr	567.1Cr	610.2Cr	554.1Cr
Other Long-Term Assets, Total	50L	40L	40L	30L	20L
Total Assets	66TCr	79TCr	84TCr	92TCr	93TCr
Liabilities
Accounts Payable, Total	3.74TCr	5.38TCr	5.57TCr	5.3TCr	5.81TCr
Accrued Expenses, Total	-	-	-	-	-
Short-term Borrowings	827.9Cr	8.28TCr	556.6Cr	287.1Cr	445.3Cr
Current Portion of Long-Term Debt	1.56TCr	3.41TCr	1.47TCr	1.03TCr	3.28TCr
Current Portion of Leases	1.24TCr	1.22TCr	936.4Cr	1.1TCr	1.1TCr
Current Income Taxes Payable	893.9Cr	2.06TCr	1.31TCr	2.39TCr	2.34TCr
Other Current Liabilities	9.19TCr	9.47TCr	9.99TCr	11TCr	11TCr
Total Current Liabilities	17TCr	30TCr	20TCr	21TCr	24TCr
Long-Term Debt	9.37TCr	9.13TCr	18TCr	25TCr	21TCr
Long-Term Leases	3.57TCr	3TCr	2.54TCr	2.04TCr	1.41TCr
Pension & Other Post Retirement Benefits	872.6Cr	756.1Cr	708.6Cr	614.6Cr	519.4Cr
Deferred Tax Liability Non Current	242.6Cr	1.02TCr	1.4TCr	1.58TCr	1.54TCr
Other Non Current Liabilities	843.1Cr	981.8Cr	829.1Cr	891.4Cr	777Cr
Total Liabilities	32TCr	45TCr	44TCr	52TCr	49TCr
Common Stock, Total	2.12TCr	2.24TCr	2.36TCr	2.47TCr	2.57TCr
Additional Paid In Capital	2.67TCr	2.83TCr	2.94TCr	3.14TCr	3.43TCr
Retained Earnings	28TCr	33TCr	32TCr	32TCr	38TCr
Treasury Stock	-1.5TCr	-6.88TCr	-627.7Cr	-1.75TCr	-4.01TCr
Comprehensive Income and Other	1.9TCr	2.86TCr	3.05TCr	4.06TCr	3.55TCr
Total Common Equity	33TCr	34TCr	40TCr	40TCr	43TCr
Minority Interest	271.1Cr	312.6Cr	339.9Cr	348.9Cr	391.8Cr
Total Equity	33TCr	34TCr	40TCr	40TCr	44TCr
Total Liabilities And Equity	66TCr	79TCr	84TCr	92TCr	93TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	60Cr	59Cr	59Cr	57Cr	57Cr
ECS Total Common Shares Outstanding	60Cr	59Cr	59Cr	58Cr	57Cr
Book Value / Share	547.66	575.59	674.35	693.33	758.67
Tangible Book Value	24TCr	13TCr	16TCr	13TCr	17TCr
Tangible Book Value Per Share	400.06	218.15	273.32	232.88	289.82
Total Debt	17TCr	25TCr	24TCr	30TCr	27TCr
Net Debt	1.24TCr	13TCr	11TCr	12TCr	10TCr
Debt Equivalent of Unfunded Proj. Benefit Obligation	-7.32TCr	-7.78TCr	-8.26TCr	-7.64TCr	-7.42TCr
Debt Equivalent Oper. Leases	-	-	-	-	-
Minority Interest, Total (Incl. Fin. Div)	271.1Cr	312.6Cr	339.9Cr	348.9Cr	391.8Cr
Equity Method Investments, Total	586.4Cr	642.7Cr	952.7Cr	979.6Cr	1.07TCr
Inventories - Work In Process, Total	-	-	-	-	-
Inventories - Finished Goods, Total	-	-	-	-	-
Full Time Employees	13.43T	16.51T	17.39T	16.71T	16.68T
Accumulated Allowance for Doubtful Accounts (Supple)	22Cr	36Cr	33Cr	39Cr	28Cr
Order Backlog	31TCr	35TCr	38TCr	40TCr	43TCr

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	7.11TCr	10TCr	11TCr	12TCr	13TCr
Depreciation & Amortization - CF	4.09TCr	4.19TCr	4.51TCr	4.82TCr	4.89TCr
Depreciation & Amortization, Total	4.09TCr	4.19TCr	4.51TCr	4.82TCr	4.89TCr
(Gain) Loss From Sale Of Asset	358.3Cr	-224.2Cr	-193.9Cr	208.1Cr	443Cr
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-6.2Cr	-20Cr	-45Cr	-78Cr	-90Cr
Other Operating Activities, Total	-2.23TCr	-2TCr	-4TCr	-2.85TCr	-4.15TCr
Change In Accounts Receivable	-781.4Cr	-920Cr	435.9Cr	-813.6Cr	-1.81TCr
Change In Inventories	40Cr	21Cr	-28Cr	11Cr	36Cr
Change In Accounts Payable	619.5Cr	337.7Cr	469.3Cr	165.6Cr	525.9Cr
Change in Other Net Operating Assets	-735.4Cr	-2.04TCr	-109.4Cr	1.05TCr	-244.7Cr
Cash from Operations	8.46TCr	9.81TCr	12TCr	14TCr	13TCr
Capital Expenditure	-763.4Cr	-682.4Cr	-1.21TCr	-748.4Cr	-666Cr
Sale of Property, Plant, and Equipment	50L	1.04TCr	690.7Cr	4.4Cr	-
Cash Acquisitions	-	-7.57TCr	-1.18TCr	-407.1Cr	-62Cr
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	-2.14TCr	-3.62TCr	-4.26TCr	-4.23TCr	-4.29TCr
Investment in Marketable and Equity Securities, Total	853Cr	-556.2Cr	-104.1Cr	7.4Cr	299.3Cr
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-1.64TCr	-	-	-
Other Investing Activities, Total	-3.2Cr	-32Cr	-58Cr	33Cr	-37Cr
Cash from Investing	-2.05TCr	-13TCr	-6.12TCr	-5.34TCr	-4.76TCr
Short Term Debt Issued, Total	497.8Cr	6.84TCr	-	-	163.4Cr
Long-Term Debt Issued, Total	2.49TCr	2.94TCr	12TCr	7.78TCr	291.8Cr
Total Debt Issued	2.99TCr	9.78TCr	12TCr	7.78TCr	455.2Cr
Short Term Debt Repaid, Total	-394.6Cr	-	-8.5TCr	-308.5Cr	-
Long-Term Debt Repaid, Total	-1.3TCr	-1.63TCr	-4.92TCr	-1.89TCr	-2.47TCr
Total Debt Repaid	-1.7TCr	-1.63TCr	-13TCr	-2.2TCr	-2.47TCr
Issuance of Common Stock	2.74TCr	675Cr	2.27TCr	503.4Cr	828.5Cr
Repurchase of Common Stock	-1TCr	-6.01TCr	-2.02TCr	-6.84TCr	-3.03TCr
Common Dividends Paid	-2.03TCr	-2.26TCr	-2.54TCr	-2.76TCr	-3.33TCr
Common & Preferred Stock Dividends Paid	-2.03TCr	-2.26TCr	-2.54TCr	-2.76TCr	-3.33TCr
Other Financing Activities, Total	-2.32TCr	-1.35TCr	-1.24TCr	-1.24TCr	-1.19TCr
Cash from Financing	-1.32TCr	-799.5Cr	-4.49TCr	-4.76TCr	-8.73TCr
Foreign Exchange Rate Adjustments	152Cr	282.9Cr	86Cr	339.9Cr	-63Cr
Miscellaneous Cash Flow Adjustments	-10L	-	-10L	-10L	-
Net Change in Cash	5.24TCr	-3.76TCr	1.36TCr	4.47TCr	-533.7Cr
Supplemental Items
Cash Interest Paid	81Cr	99Cr	399.1Cr	589.1Cr	586Cr
Cash Income Tax Paid (Refund)	3.25TCr	2.19TCr	4.09TCr	2.85TCr	3.96TCr
Levered Free Cash Flow	5.83TCr	4.54TCr	5.36TCr	7.92TCr	6.06TCr
Unlevered Free Cash Flow	5.89TCr	4.63TCr	5.66TCr	8.31TCr	6.41TCr
Change In Net Working Capital	478.4Cr	1.69TCr	231.5Cr	-1.04TCr	1.88TCr
Net Debt Issued / Repaid	1.29TCr	8.15TCr	-966.9Cr	5.58TCr	-2.01TCr

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	8.71	8.87	8.41	8.44	9.04
Return on Total Capital	11.62	11.75	11.11	11.08	11.86
Return On Equity %	16.95	21.25	20.54	19.91	22.45
Return on Common Equity	17.55	21.33	20.67	19.95	22.5
Margin Analysis
Gross Profit Margin %	33.76	35.33	34.65	35.44	36
SG&A Margin	17.87	18.56	19.01	19.33	18.84
EBITDA Margin %	22.5	23.64	22.35	22.69	23.89
EBITA Margin %	15.06	16.78	15.83	16.15	17.5
EBIT Margin %	15.06	16.78	15.83	16.15	17.5
Income From Continuing Operations Margin %	9.55	11.74	11.05	10.88	12.34
Net Income Margin %	9.61	11.68	11.02	10.81	12.26
Net Avail. For Common Margin %	9.61	11.68	11.02	10.81	12.26
Normalized Net Income Margin	8.38	10.3	9.61	9.82	10.87
Levered Free Cash Flow Margin	10.59	7.42	7.74	10.76	7.92
Unlevered Free Cash Flow Margin	10.71	7.56	8.17	11.28	8.39
Asset Turnover
Asset Turnover	0.93	0.85	0.85	0.84	0.83
Fixed Assets Turnover	7.16	7.34	9.2	10.3	11.79
Receivables Turnover (Average Receivables)	4.62	5.05	5.18	5.39	5.1
Inventory Turnover (Average Inventory)	-	-	-	-	-
Short Term Liquidity
Current Ratio	1.85	1.12	1.76	1.89	1.75
Quick Ratio	1.49	0.84	1.32	1.47	1.36
Operating Cash Flow to Current Liabilities	0.49	0.33	0.6	0.66	0.54
Days Sales Outstanding (Average Receivables)	78.97	72.21	70.47	67.94	71.63
Days Outstanding Inventory (Average Inventory)	-	-	-	-	-
Average Days Payable Outstanding	-	42.06	44.17	41.84	41.45
Cash Conversion Cycle (Average Days)	-	-	-	-	-
Long Term Solvency
Total Debt/Equity	49.7	73.12	59.08	74.08	61.88
Total Debt / Total Capital	33.2	42.24	37.14	42.55	38.23
LT Debt/Equity	38.83	35.4	51.73	68.06	50.85
Long-Term Debt / Total Capital	25.94	20.45	32.52	39.1	31.41
Total Liabilities / Total Assets	49.25	56.63	51.99	56.32	52.83
EBIT / Interest Expense	82.49	74.28	22.8	19.51	23.54
EBITDA / Interest Expense	123.2	104.63	32.18	27.41	32.15
(EBITDA - Capex) / Interest Expense	115.6	99.69	29.67	26.19	30.98
Total Debt / EBITDA	1.34	1.73	1.54	1.79	1.48
Net Debt / EBITDA	0.1	0.93	0.7	0.75	0.56
Total Debt / (EBITDA - Capex)	1.43	1.82	1.67	1.87	1.54
Net Debt / (EBITDA - Capex)	0.11	0.98	0.76	0.78	0.58
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	4.06	11.14	13.17	6.41	3.84
Gross Profit, 1 Yr. Growth %	2.73	16.29	10.99	8.83	5.47
EBITDA, 1 Yr. Growth %	9	16.79	6.97	8.03	9.36
EBITA, 1 Yr. Growth %	-0.33	23.83	6.74	8.54	12.52
EBIT, 1 Yr. Growth %	-0.33	23.83	6.74	8.54	12.52
Earnings From Cont. Operations, 1 Yr. Growth %	-25.11	36.54	6.55	4.79	17.74
Net Income, 1 Yr. Growth %	-23.69	35.14	6.81	4.37	17.73
Normalized Net Income, 1 Yr. Growth %	-11.18	36.61	5.59	8.75	14.94
Diluted EPS Before Extra, 1 Yr. Growth %	-19.2	36.56	7.1	6.18	19.53
Accounts Receivable, 1 Yr. Growth %	-19.34	27.61	-3.01	7.81	11.58
Inventory, 1 Yr. Growth %	-	-	-	-	-
Net Property, Plant and Equip., 1 Yr. Growth %	42.37	-15.33	-3.22	-6.62	-12.21
Total Assets, 1 Yr. Growth %	23.14	20.28	6.15	10.09	0.62
Tangible Book Value, 1 Yr. Growth %	29.18	-46.73	25.74	-17.02	23.55
Common Equity, 1 Yr. Growth %	21.5	2.68	17.58	0.13	8.64
Cash From Operations, 1 Yr. Growth %	-17.7	16.01	21.16	19.66	-8.49
Capital Expenditures, 1 Yr. Growth %	53.45	-10.61	76.74	-37.95	-11.01
Levered Free Cash Flow, 1 Yr. Growth %	-20.82	-22.1	17.96	47.96	-23.55
Unlevered Free Cash Flow, 1 Yr. Growth %	-20.31	-21.47	22.25	46.83	-22.78
Dividend Per Share, 1 Yr. Growth %	12.5	11.11	12.5	17.78	18.87
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	4.78	7.54	12.15	9.74	5.12
Gross Profit, 2 Yr. CAGR %	6.2	9.3	13.61	9.91	7.14
EBITDA, 2 Yr. CAGR %	10.25	12.83	11.77	7.5	8.7
EBITA, 2 Yr. CAGR %	7.72	11.09	14.97	7.64	10.51
EBIT, 2 Yr. CAGR %	7.72	11.09	14.97	7.64	10.51
Earnings From Cont. Operations, 2 Yr. CAGR %	1.01	1.12	20.62	5.67	11.08
Net Income, 2 Yr. CAGR %	1.88	1.55	20.14	5.58	10.85
Normalized Net Income, 2 Yr. CAGR %	1.61	10.16	20.1	7.16	11.8
Diluted EPS Before Extra, 2 Yr. CAGR %	10.68	5.04	20.94	6.64	12.65
Accounts Receivable, 2 Yr. CAGR %	-10.8	1.45	11.25	2.26	9.68
Inventory, 2 Yr. CAGR %	-	-	-	-	-
Net Property, Plant and Equip., 2 Yr. CAGR %	17.52	9.79	-9.48	-4.93	-9.45
Total Assets, 2 Yr. CAGR %	3.56	21.7	12.99	8.1	5.25
Tangible Book Value, 2 Yr. CAGR %	-13.2	-17.04	-18.16	2.15	1.26
Common Equity, 2 Yr. CAGR %	-10.43	11.7	9.88	8.5	4.3
Cash From Operations, 2 Yr. CAGR %	22.53	-2.29	18.55	20.41	4.64
Capital Expenditures, 2 Yr. CAGR %	17.53	17.12	25.69	4.72	-25.69
Levered Free Cash Flow, 2 Yr. CAGR %	28.31	-21.46	-4.14	32.11	6.36
Unlevered Free Cash Flow, 2 Yr. CAGR %	28.5	-20.89	-2.02	33.98	6.48
Dividend Per Share, 2 Yr. CAGR %	9.54	11.8	11.8	15.11	18.32
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	5.29	6.86	9.38	10.2	7.73
Gross Profit, 3 Yr. CAGR %	5.19	9.46	9.86	12	8.41
EBITDA, 3 Yr. CAGR %	8.45	12.39	10.84	10.51	8.12
EBITA, 3 Yr. CAGR %	8.37	12.84	9.62	12.78	9.24
EBIT, 3 Yr. CAGR %	8.37	12.84	9.62	12.78	9.24
Earnings From Cont. Operations, 3 Yr. CAGR %	-2.18	11.68	2.9	15.09	9.55
Net Income, 3 Yr. CAGR %	-1.4	11.94	3.27	14.64	9.48
Normalized Net Income, 3 Yr. CAGR %	4.56	12.14	8.61	16.19	9.69
Diluted EPS Before Extra, 3 Yr. CAGR %	5.13	18.71	5.72	15.8	10.77
Accounts Receivable, 3 Yr. CAGR %	-2.8	0.51	-0.06	10.09	5.27
Inventory, 3 Yr. CAGR %	-	-	-	-	-
Net Property, Plant and Equip., 3 Yr. CAGR %	9.63	5.35	5.27	-8.53	-7.42
Total Assets, 3 Yr. CAGR %	0.2	8.86	16.28	12.02	5.55
Tangible Book Value, 3 Yr. CAGR %	-8.76	-26.24	-4.71	-17.78	8.84
Common Equity, 3 Yr. CAGR %	-7.72	-6.26	13.62	6.53	8.55
Cash From Operations, 3 Yr. CAGR %	4.8	20.31	4.97	18.92	9.88
Capital Expenditures, 3 Yr. CAGR %	-23.32	7.28	34.34	-0.66	-0.81
Levered Free Cash Flow, 3 Yr. CAGR %	18.75	8.65	-10.06	10.78	10.09
Unlevered Free Cash Flow, 3 Yr. CAGR %	18.89	9.05	-8.54	12.13	11.5
Dividend Per Share, 3 Yr. CAGR %	10.52	10.06	12.04	13.76	16.35
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	5.48	7.58	7.98	8	7.66
Gross Profit, 5 Yr. CAGR %	6.73	8.49	8.48	9.64	8.76
EBITDA, 5 Yr. CAGR %	6.38	10.7	9.76	10.4	9.98
EBITA, 5 Yr. CAGR %	7.3	11.9	10.96	10.73	9.98
EBIT, 5 Yr. CAGR %	7.3	11.9	10.96	10.73	9.98
Earnings From Cont. Operations, 5 Yr. CAGR %	4.21	10.31	6.37	9.24	6.1
Net Income, 5 Yr. CAGR %	4.39	9.66	6.71	9.35	6.24
Normalized Net Income, 5 Yr. CAGR %	3.95	10.15	10.52	10.12	9.88
Diluted EPS Before Extra, 5 Yr. CAGR %	9.11	14.75	11.19	13.72	8.44
Accounts Receivable, 5 Yr. CAGR %	0.43	6.85	2.59	1.2	3.73
Inventory, 5 Yr. CAGR %	-	-	-	-	-
Net Property, Plant and Equip., 5 Yr. CAGR %	6.67	3.69	1.55	1.11	-0.89
Total Assets, 5 Yr. CAGR %	1.1	4.66	5.13	8.55	11.73
Tangible Book Value, 5 Yr. CAGR %	-7.02	-17.48	-12.64	-15.98	-2.37
Common Equity, 5 Yr. CAGR %	-4.34	-4.87	-1.05	-0.61	9.8
Cash From Operations, 5 Yr. CAGR %	0.76	9.92	10.1	20.35	4.84
Capital Expenditures, 5 Yr. CAGR %	-16.83	-12.79	-6.56	6.25	6.01
Levered Free Cash Flow, 5 Yr. CAGR %	5.97	13.99	9	17.48	-3.82
Unlevered Free Cash Flow, 5 Yr. CAGR %	6.15	14.3	10.04	18.41	-2.8
Dividend Per Share, 5 Yr. CAGR %	8.23	9.46	11.03	12.05	14.51